ClinicalTrials.Veeva

Menu

Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilities

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status and phase

Begins enrollment in 2 months
Phase 2

Conditions

Cerebral Palsy (CP)

Treatments

Behavioral: Extended Reality Exergaming

Study type

Interventional

Funder types

Other

Identifiers

NCT07564934
UAB (Other Grant/Funding Number)
IRB-300016599

Details and patient eligibility

About

This phase II RCT evaluates the efficacy of a telehealth-delivered extended reality (XR) exergaming intervention on physical activity, cardiometabolic health, and physical fitness in physically inactive children with cerebral palsy (ages 10 to 17). A total of 130 participants will be randomized to either a 12-week XR exergaming intervention with behavioral coaching or a non-intervention control group, followed by a 24-week sustainability phase. Aim 1 examines immediate and sustained effects on physical activity levels. Aim 2 tests effects on cardiometabolic health indicators including blood lipids, blood pressure, and glycemic markers. Aim 3 explores effects on physical fitness and perceived health. All procedures are conducted remotely via telehealth.

Enrollment

130 estimated patients

Sex

All

Ages

10 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. medical diagnosis of cerebral palsy
  2. between the ages of 10-17 years (10 years of age is the minimum requirement of the Meta Quest 3s headset, as noted by the manufacturer)
  3. physician clearance to participate in moderate-intensity exercise
  4. access to a Wi-Fi Internet connection in the home
  5. a caregiver that is committed to supporting the child with setting up and assisting with the prescribed exergaming and managing the study activities

Exclusion criteria

  1. physically active (defined as ≥150 minutes per week of moderate-to-vigorous intensity exercise in a typical week)
  2. prone to photosensitive seizures
  3. a classification of GMFCS level V, which we have found to preclude the ability to use the Oculus Quest hand-held controllers
  4. complete blindness or deafness
  5. unable to communicate in English (participant and caregiver)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

130 participants in 2 patient groups

Extended Reality Gaming (XRG)
Experimental group
Description:
Immediate start of extended reality exercise program for 36 weeks.
Treatment:
Behavioral: Extended Reality Exergaming
Non-intervention Control
No Intervention group
Description:
Continue habitual activities for 36 weeks.

Trial contacts and locations

2

Loading...

Central trial contact

Byron Lai, MS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems